Gerald McLaughlin
Chief Executive Officer bei NEOS THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Profil
Gerald W.
McLaughlin is currently the Chief Executive Officer & Director at Neos Therapeutics, Inc., the Chief Executive Officer & Director at Life Biosciences, Inc., the Independent Chairman at Allarity Therapeutics A, and the Chairman at Allarity Therapeutics, Inc. He previously served as the President, Chief Executive Officer & Director at AgeneBio, Inc. from 2014 to 2018, the President, Chief Executive Officer & Director at Neos Therapeutics, Inc. from 2018 to 2021, the Associate Director-Marketing at Merck & Co., Inc. from 1990 to 2001, the Senior Director-Strategic Marketing at Endo Pharmaceuticals, Inc. in 2007, an Independent Director at Skye Bioscience, Inc. from 2014 to 2018, a Director at Aytu Biopharma, Inc. in 2021, and the Chief Commercial Officer & Senior Vice President at NuPathe, Inc. from 2013 to 2014.
He holds an undergraduate degree from Dickinson College and an MBA from Villanova School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.02.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Gerald McLaughlin
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Chairman | 19.01.2023 |
| NEOS THERAPEUTICS, INC. | Chief Executive Officer | - |
Life Biosciences, Inc.
 Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Chief Executive Officer | 01.07.2021 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Chairman | - |
Ehemalige bekannte Positionen von Gerald McLaughlin
| Unternehmen | Position | Ende |
|---|---|---|
| AYTU BIOPHARMA, INC. | Director/Board Member | 17.05.2021 |
| NEOS THERAPEUTICS, INC. | Chief Executive Officer | 19.03.2021 |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Chief Executive Officer | 01.06.2018 |
| SKYE BIOSCIENCE, INC. | Director/Board Member | 18.01.2018 |
| NUPATHE INC | Chief Operating Officer | 21.06.2011 |
Ausbildung von Gerald McLaughlin
| Dickinson College | Undergraduate Degree |
| Villanova School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SKYE BIOSCIENCE, INC. | Health Technology |
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| AYTU BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Electronic Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
